Accommodation Measurements After Bilateral Implantation of an Aspheric Accommodating Lens and Monofocal Aspheric Lenses

Inclusion Criteria: * Subjects must have clear intraocular media other than cataract. * Subjects must have a clinically documented diagnosis of age-related bilateral cataracts that are considered amenable to treatment with standard phacoemulsification cataract extraction. * Subjects must be undergoing primary IOL implantation for the correction of aphakia following central continuous curvilinear anterior capsulorrhexis and phacoemulsification cataract extraction. * Subjects must require a spherical lens power from 10.00 D to 30.00 D. * Subjects must be willing and able to return for all scheduled follow-up examinations for each eye from days 1 through 180 following surgery. * Subjects must have ≤ 1.25 D of preoperative corneal astigmatism. Exclusion Criteria: * Subjects with corneal pathology potentially affecting topography. * Subjects whose fundus cannot be assessed preoperatively. * Subjects with diagnoses of degenerative visual disorders (eg, macular degeneration, or other retinal disorders) that cause potential acuity losses to a level worse than 20/30 as verified by OCT. * Subjects with conditions with increased risk of zonular rupture, such as pseudoexfoliation syndrome. * Subjects who have any active inflammation or edema (swelling) of the cornea, including but not limited to the following: keratitis, keratoconjunctivitis, and keratouveitis. * Subjects with uncontrolled glaucoma. * Subjects with previous retinal detachment. * Subjects with visually significant diabetic retinopathy (proliferative or non-proliferative) which reduces potential acuity to 20/30 or worse. * Subjects with rubella, bilateral congenital, traumatic, complicated or polar cataract. * Subjects with marked microphthalmos or aniridia. * Subjects who have had previous corneal surgery. * Subjects with irregular corneal astigmatism. * Subjects with amblyopia which reduces potential acuity to worse than 20/30. * Subjects with optic atrophy. * Subjects with iris neovascularization. * Subjects with clinically significant retinal pigment epithelium/macular changes which reduces potential acuity to 20/30 or worse. * Subjects with chronic use of systemic steroids or immunosuppressive medications. * Subjects lacking intact binocular vision.